PELIZZARO, FILIPPO
 Distribuzione geografica
Continente #
NA - Nord America 2.094
AS - Asia 1.973
EU - Europa 1.404
AF - Africa 500
SA - Sud America 424
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 29
Totale 6.473
Nazione #
US - Stati Uniti d'America 1.821
SG - Singapore 820
IT - Italia 404
BR - Brasile 271
HK - Hong Kong 253
CN - Cina 248
VN - Vietnam 135
DE - Germania 129
FI - Finlandia 82
PL - Polonia 81
NL - Olanda 68
GB - Regno Unito 59
FR - Francia 57
RU - Federazione Russa 54
ID - Indonesia 37
JP - Giappone 34
SE - Svezia 34
MX - Messico 30
TR - Turchia 29
AR - Argentina 28
IN - India 28
AT - Austria 26
CA - Canada 26
ZA - Sudafrica 26
IE - Irlanda 25
EC - Ecuador 24
BJ - Benin 22
ES - Italia 22
CZ - Repubblica Ceca 21
LB - Libano 21
LY - Libia 21
DK - Danimarca 20
MA - Marocco 20
UA - Ucraina 20
BE - Belgio 19
GT - Guatemala 19
HN - Honduras 19
LC - Santa Lucia 19
CH - Svizzera 18
EG - Egitto 18
ME - Montenegro 18
TH - Thailandia 18
AU - Australia 17
AZ - Azerbaigian 17
IQ - Iraq 17
IR - Iran 17
JO - Giordania 17
MK - Macedonia 17
RS - Serbia 17
AO - Angola 16
BO - Bolivia 16
CL - Cile 16
GN - Guinea 16
HU - Ungheria 16
LA - Repubblica Popolare Democratica del Laos 16
LU - Lussemburgo 16
PH - Filippine 16
RW - Ruanda 16
TJ - Tagikistan 16
CV - Capo Verde 15
KR - Corea 15
NE - Niger 15
PY - Paraguay 15
TT - Trinidad e Tobago 15
XK - ???statistics.table.value.countryCode.XK??? 15
AE - Emirati Arabi Uniti 14
BF - Burkina Faso 14
CD - Congo 14
CU - Cuba 14
EE - Estonia 14
KE - Kenya 14
MU - Mauritius 14
PK - Pakistan 14
PT - Portogallo 14
BS - Bahamas 13
CO - Colombia 13
CW - ???statistics.table.value.countryCode.CW??? 13
LV - Lettonia 13
NO - Norvegia 13
PE - Perù 13
PS - Palestinian Territory 13
SD - Sudan 13
SK - Slovacchia (Repubblica Slovacca) 13
TW - Taiwan 13
AM - Armenia 12
CG - Congo 12
CR - Costa Rica 12
DO - Repubblica Dominicana 12
DZ - Algeria 12
GE - Georgia 12
GF - Guiana Francese 12
GM - Gambi 12
GR - Grecia 12
NP - Nepal 12
PR - Porto Rico 12
RO - Romania 12
TZ - Tanzania 12
UG - Uganda 12
UZ - Uzbekistan 12
BA - Bosnia-Erzegovina 11
Totale 5.960
Città #
Singapore 447
Ashburn 331
Hong Kong 235
Fairfield 169
New York 137
Chandler 111
Beijing 92
Santa Clara 75
Munich 60
Houston 59
Woodbridge 59
Boardman 52
Padova 52
Los Angeles 51
Bytom 47
Cambridge 47
Ho Chi Minh City 47
Milan 40
Seattle 36
Turku 32
Wilmington 29
San Diego 27
São Paulo 27
Lappeenranta 25
Medford 25
Princeton 25
San Jose 24
Tokyo 24
Hanoi 23
Cotonou 22
Helsinki 22
Hefei 20
Warsaw 20
Dublin 19
Ann Arbor 18
Castries 18
London 17
Nuremberg 17
Buffalo 16
Chicago 16
Conakry 16
Kigali 16
Amman 15
Baku 15
Brooklyn 15
Podgorica 15
Roxbury 15
Denver 14
Dushanbe 14
Guangzhou 14
Kinshasa 14
Quito 14
Vienna 14
Vientiane 14
Arezzo 13
Des Moines 13
Frankfurt am Main 13
Istanbul 13
Luanda 13
Montreal 13
Nassau 13
Niamey 13
Orem 13
Padua 13
Kampala 12
Nairobi 12
Naples 12
Tallinn 12
Tashkent 12
Tripoli 12
Boston 11
Bridgetown 11
Djibouti 11
Havana 11
Johannesburg 11
Libreville 11
Lusaka 11
Luxembourg 11
Praia 11
Seoul 11
Verona 11
Willemstad 11
Cairo 10
Dakar 10
Mexico City 10
Ouagadougou 10
Poplar 10
Riga 10
Rome 10
San José 10
Skopje 10
Tbilisi 10
Venice 10
Villafranca Padovana 10
Abidjan 9
Amsterdam 9
Andorra la Vella 9
Athens 9
Bamako 9
Cagliari 9
Totale 3.326
Nome #
Capecitabine in advanced hepatocellular carcinoma: A multicenter experience 256
Management of hepatocellular carcinoma recurrence after liver transplantation 214
Monofocal hepatocellular carcinoma: How much does size matter? 197
CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma 191
SCCA-IgM in hepatocellular carcinoma patients treated with transarterial chemoembolization: gender-related differences 176
Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens 171
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 171
Liquid biopsy in hepatocellular carcinoma: Where are we now? 158
Pattern of macrovascular invasion in hepatocellular carcinoma 150
Liver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysis 149
Coffee and hepatocellular carcinoma: Epidemiologic evidence and biologic mechanisms 149
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 144
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 141
Gastric cancer screening in Western countries: A call to action 140
Autoimmune Atrophic Gastritis: The Role of miRNA in Relation to Helicobacter Pylori Infection 136
The risk of malignancies in celiac disease—A literature review 135
Boost: A phase 3 trial of sorafenib vs. best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver function 134
Alcoholic Etiology, Severity of Liver Disease, and Post-Transplant Adherence Are Correlated with Worse Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Liver Transplant Candidates 133
Circulating prostaglandin E2: a novel potential prognostic biomarker in patients with hepatocellular carcinoma 127
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 127
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 118
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 118
Eosinophilic esophagitis: from pathophysiology to management 116
Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis 115
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care 115
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance 114
Crosstalk between MicroRNAs and Oxidative Stress in Coeliac Disease 111
Circulating microrna-21 and microrna-122 as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization 111
Letter: is female sex really associated with better prognosis in hepatocellular carcinoma? 111
Multiple hepatic cysts in an adult male 110
Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients 110
Systemic therapies for hepatocellular carcinoma: An evolving landscape 109
Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies 106
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 106
Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications 104
Bacterial Infections in End-Stage Liver Disease: Implications for Liver Transplantation 99
Efficacy of immunotherapy in hepatocellular carcinoma: Does liver disease etiology have a role? 98
Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study 97
Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges 93
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma 93
Machine learning in liver transplantation: a tool for some unsolved questions? 91
Treatment of hepatocellular carcinoma with immune checkpoint inhibitors and applicability of first-line atezolizumab/bevacizumab in a real-life setting 90
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 88
A rare cause of painful hepatomegaly 86
Eosinophilic esophagitis and biologics 84
HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization 81
Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma 80
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted Comparison 78
Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC 76
BIOMARCATORI CIRCOLANTI E FATTORI CLINICI ASSOCIATI CON LA PROGNOSI NEI PAZIENTI CON CARCINOMA EPATOCELLULARE 75
Patient journey in gastroesophageal reflux disease: real-world perspectives from Italian gastroenterologists, primary care physicians, and ENT specialists 68
Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0 65
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 64
Outcome of hepatic resection for HCC in ideal and non-ideal candidates 37
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison 36
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study 31
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma 27
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study 23
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis 18
null 13
Totale 6.564
Categoria #
all - tutte 22.224
article - articoli 21.970
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.194


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 0 0 5 41 14 12 6 64
2021/2022371 9 22 11 16 10 41 53 45 18 20 42 84
2022/2023283 62 9 26 26 42 32 6 16 33 5 21 5
2023/2024372 21 40 41 22 13 45 71 13 17 20 31 38
2024/20251.537 12 96 63 46 130 48 90 93 168 115 274 402
2025/20263.745 361 448 924 1.014 582 385 31 0 0 0 0 0
Totale 6.564